Back
180 Life Sciences Vs. Theriva Biologics Industry Stock Comparison
Buy
54
ATNF
180 Life Sciences
Last Price:
3.02
Seasonality Move:
-32.8%
Buy
52
TOVX
Theriva Biologics
Last Price:
2.00
Seasonality Move:
51.28%
Buy
54
180 Life Sciences (ATNF)
is a Buy
Is 180 Life Sciences a Buy, Sell or Hold?
- The current 180 Life Sciences [ATNF] share price is $3.17. The Score for ATNF is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- ATNF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
52
Theriva Biologics (TOVX)
is a Buy
Is Theriva Biologics a Buy, Sell or Hold?
- The current Theriva Biologics [TOVX] share price is $1.97. The Score for TOVX is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- TOVX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ATNF Stock Price Chart
What is 180 Life Sciences's stock price today?
-
The 180 Life Sciences share price today is $3.17
The current trend is moderately bearish and ATNF is experiencing selling pressure, which indicates risk of future bearish movement.
TOVX Stock Price Chart
What is Theriva Biologics's stock price today?
-
The Theriva Biologics share price today is $1.97
The current trend is relatively stagnant and TOVX is experiencing selling pressure, which indicates risk of future bearish movement.
ATNF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.39 | Buy |
| Relative Strength Index (14 RSI): | 48.78 | Sell |
| Chaikin Money Flow: | -247247 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.58 - 4.7) | Buy |
| Bollinger Bands (100): | (1.24 - 3.18) | Buy |
TOVX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.17 | Sell |
| Relative Strength Index (14 RSI): | 52.5 | Buy |
| Chaikin Money Flow: | -674088 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.36 - 1.76) | Buy |
| Bollinger Bands (100): | (2.2 - 6.16) | Sell |
ATNF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.89 | Sell |
| 20-day SMA: | 3.58 | Sell |
| 50-day SMA: | 2.51 | Buy |
| 200-day SMA: | 2.45 | Buy |
| 8-day EMA: | 3.71 | Sell |
| 20-day EMA: | 3.5 | Sell |
| 50-day EMA: | 2.84 | Buy |
| 200-day EMA: | 8.49 | Sell |
TOVX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.69 | Buy |
| 20-day SMA: | 1.57 | Buy |
| 50-day SMA: | 2.55 | Sell |
| 200-day SMA: | 7.37 | Sell |
| 8-day EMA: | 1.76 | Buy |
| 20-day EMA: | 1.77 | Buy |
| 50-day EMA: | 2.58 | Sell |
| 200-day EMA: | 6.8 | Sell |
180 Life Sciences Earnings Growth & ATNF Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.00 per share, and a decrease next year of $0.00 per share.
Theriva Biologics Earnings Growth & TOVX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.00 per share, and an increase next year of $22.60 per share.
180 Life Sciences Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Theriva Biologics Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||